APA (7th ed.) Citation

Diamant, A., Chatterjee, A., Faria, S., Naqa, I. E., Bahig, H., Filion, E., . . . Seuntjens, J. (2018). Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)? Radiotherapy & Oncology, 128(3), 513. https://doi.org/10.1016/j.radonc.2018.05.012

Chicago Style (17th ed.) Citation

Diamant, André, Avishek Chatterjee, Sergio Faria, Issam El Naqa, Houda Bahig, Edith Filion, Cliff Robinson, Hani Al-Halabi, and Jan Seuntjens. "Can Dose Outside the PTV Influence the Risk of Distant Metastases in Stage I Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT)?" Radiotherapy & Oncology 128, no. 3 (2018): 513. https://doi.org/10.1016/j.radonc.2018.05.012.

MLA (9th ed.) Citation

Diamant, André, et al. "Can Dose Outside the PTV Influence the Risk of Distant Metastases in Stage I Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT)?" Radiotherapy & Oncology, vol. 128, no. 3, 2018, p. 513, https://doi.org/10.1016/j.radonc.2018.05.012.